Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Newtyn Management, LLC

Q2 2023 · 13F-HR

Newtyn Management, LLCholdings as filed

Filed 2023-08-14 · accession 0001493152-23-028373

$423.3M
Reported value
46
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
44891N208IACIAC INC$56.5M13.4%900,000CommonSOLE
13765N107CNNECANNAE HLDGS INC$40.6M9.60%2,010,663CommonSOLE
36237H101GIIIG III APPAREL GROUP LTD$31.7M7.49%1,645,452CommonSOLE
698884103PARPAR TECHNOLOGY CORP$29.6M7.00%900,000CommonSOLE
L02235106AMBPARDAGH METAL PACKAGING S A$26.3M6.22%7,000,000CommonSOLE
590328209MACKEURMERRIMACK PHARMACEUTICALS IN$23.0M5.44%1,873,694CommonSOLE
84790A105SPBSPECTRUM BRANDS HLDGS INC NE$19.5M4.61%249,937CommonSOLE
11040G103VTOLBRISTOW GROUP INC$19.4M4.58%674,270CommonSOLE
178587101CIOCITY OFFICE REIT INC$17.0M4.03%3,059,721CommonSOLE
G8807B106TBPHTHERAVANCE BIOPHARMA INC$17.0M4.01%1,640,456CommonSOLE
68629Y103ONLORION OFFICE REIT INC$15.1M3.58%2,290,000CommonSOLE
55262C100MBIMBIA INC$12.1M2.85%1,395,000CommonSOLE
366505105GTXGARRETT MOTION INC$11.2M2.65%1,482,149CommonSOLE
36315X101LKFTGALAPAGOS NV$11.0M2.59%270,000CommonSOLE
71722W107PHATPHATHOM PHARMACEUTICALS INC$9.8M2.31%683,648CommonSOLE
901384107TSVT*2SEVENTY BIO INC$7.5M1.76%737,744CommonSOLE
65342T106NODKNI HLDGS INC$6.8M1.61%460,000CommonSOLE
50015M109KODKODIAK SCIENCES INC$6.8M1.61%989,703CommonSOLE
886885102TLYSTILLYS INC$5.6M1.32%800,000CommonSOLE
34984VAC4FORUM ENERGY TECHNOLOGIES IN$5.4M1.28%5,483,872CommonSOLE
25065K104DXLGDESTINATION XL GROUP INC$5.4M1.27%1,100,000CommonSOLE
85512G106STHOSTAR HLDGS$4.8M1.12%324,472CommonSOLE
69331C108PCGPG&E CORP$4.6M1.10%268,921CommonSOLE
34984V209FETFORUM ENERGY TECHNOLOGIES IN$4.6M1.09%180,000CommonSOLE
015658107ASTLALGOMA STL GROUP INC$4.2M0.99%590,899CommonSOLE
282559103ETNBGBP89BIO INC$3.8M0.90%200,000CommonSOLE
23284P103CYTEIR THERAPEUTICS INC$3.5M0.83%1,358,049CommonSOLE
717098206PFSWEB INC$3.4M0.80%746,406CommonSOLE
03212B103AMPYAMPLIFY ENERGY CORP NEW$2.7M0.63%393,214CommonSOLE
81728A108SNSEEURSENSEI BIOTHERAPEUTICS INC$2.1M0.49%1,827,240CommonSOLE
Y95308105WVEWAVE LIFE SCIENCES LTD$1.8M0.43%500,000CommonSOLE
699374302PARATEK PHARMACEUTICALS INC$1.7M0.40%764,274CommonSOLE
00773U108ADVMCHFADVERUM BIOTECHNOLOGIES INC$1.6M0.38%1,000,000CommonSOLE
68062P106OLMAOLEMA PHARMACEUTICALS INC$1.6M0.37%175,000CommonSOLE
097702104BOLT1EURBOLT BIOTHERAPEUTICS INC$1.3M0.30%1,000,000CommonSOLE
09203E105BDTXBLACK DIAMOND THERAPEUTICS I$1.0M0.24%200,000CommonSOLE
01626L105ALIGOS THERAPEUTICS INC$873,9000.21%900,000CommonSOLE
24343R106DECIBEL THERAPEUTICS INC$770,0000.18%200,000CommonSOLE
00211Y506ABIOEURARCA BIOPHARMA INC$635,7960.15%313,200CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$333,5970.08%89,197CommonSOLE
513272104LWLAMB WESTON HLDGS INC$247,9470.06%2,157CommonSOLE
37890B100GBTGGLOBAL BUSINESS TRAVEL GROUP$223,5730.05%30,923CommonSOLE
G1643W137BRILLIANT ACQUISITION CORP$63,8090.02%457,409CommonSOLE
040450124ARISZ ACQUISITION CORP$22,2000.01%250,000CommonSOLE
52178J113LFLYWLEAFLY HOLDINGS INC$19,2300.00%634,640CommonSOLE
92853V122VIVEON HEALTH ACQUISITION CO$14,3250.00%250,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.